Minerva Neurosciences (NERV) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

5

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.15

Median Target+80.72%

$7.50

Potential upside vs current price

DCF Value-52.37%

$1.98

Potential downside vs current price

Current Stock Price

$4.15

Median Target+80.72%

$7.50

Potential upside vs current price

DCF Value-52.37%

$1.98

Potential downside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

5

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.15

Median Target+80.72%

$7.50

Potential upside vs current price

DCF Value-52.37%

$1.98

Potential downside vs current price

Current Stock Price

$4.15

Median Target+80.72%

$7.50

Potential upside vs current price

DCF Value-52.37%

$1.98

Potential downside vs current price

Minerva Neurosciences, Inc.